Risdiplam-hydroxylate-d3 | MedChemExpress (MCE)
Risdiplam-hydroxylate-d3 is a Risdiplam-hydroxylate tritium substitute. Risdiplam (RG7916) is an orally administered, centrally and peripherally distributed SMN2 pre-mRNA splicing modifier that increases survival motor neuron (SMN) protein levels[1].
| Trivial name | Risdiplam-hydroxylate-d3 |
| Catalog Number | HY-109101AS1 |
| Research Area | Neurological Disease |
| Purity | ≥98.0% |
| SMILES | O=C1C=C(C2=NN3C=C(C)N=C3C(C([2H])([2H])[2H])=C2)N=C4C=CC(N5CCN(C6(CC6)C5)O)=CN14 |
| Size | 1 mg |
| Supplier Page | https://www.medchemexpress.com/risdiplam-hydroxylate-d3.html |